BD Names CEO Tom Polen as Chairman of the Board
"In Tom's first year as CEO, he faced unprecedented challenges from the global COVID-19 pandemic, and successfully guided the company to assist in the pandemic, while also advancing the focus and commitment to quality and compliance across the organization," said
"I'd also like to thank Vince for his lifetime commitment to making BD a better company for its customers, employees and investors," Larsen continued. "Vince led the company through its greatest transformation in its more than 120-year history. The culmination of Vince's legacy included the acquisitions of
Polen, , joined BD in 1999, and has held a variety of leadership roles at numerous business units. He was appointed president of BD in
"It is truly an honor to lead this innovative company, particularly at this critical time in the health care industry," said Polen. "BD's success has always been a collective achievement, driven by the hard work and unwavering commitment of our employees around the globe. I'm proud of the way our team has responded to the greatest health care crisis in a century by rallying around the company's purpose and embracing the values that drive the culture of growth through innovation, quality and compliance across our organization. We will continue to rely on their passion and support to help us in advancing the world of health for our customers and their patients. I look forward to working with our board of directors and the global BD team to continue to drive the BD 2025 strategy of Grow, Simplify and Empower."
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/bd-names-ceo-tom-polen-as-chairman-of-the-board-301214616.html
SOURCE BD (